Key result
siRNAs targeting the 3C coding region of Coxsackievirus B3 achieved 95% inhibition of viral replication in vitro at a concentration of 40 nmol/L with no cytotoxicity.
Why the study?
Post-transcriptional gene silencing provides an effective approach for viral replication control, motivating the evaluation of dsRNAs and siRNA pools targeting essential Coxsackievirus B3 cardiotropic strain Woodruff genes.
Does silencing essential viral genes using dsRNAs and siRNAs inhibit Coxsackievirus B3 replication in vitro?
Does silencing essential viral genes using dsRNAs and siRNAs inhibit Coxsackievirus B3 replication in vitro?
Answers are grounded in this paper and cite their sources.
siRNAs targeting the 3C coding region effectively inhibit Coxsackievirus B3 replication in vitro without significant cytotoxicity, suggesting a potential therapeutic strategy for viral myocarditis.
Post-transcriptional gene silencing is an effective tool for viral replication control at the epigenetic level. In this study, we aimed to produce dsRNAs and siRNA pools targeting the genetic region for the viral protease 3C and the genetic region covering the sequences for VP1 and VP3 capsid proteins of the Coxsackievirus B3 cardiotropic Woodruff strain by the use of the polymerase complex of bacteriophage Phi6 in HEp-2 monolayer cells. The dsRNAs obtained in this study, specific for the 3C and VP1-VP3 genetic regions of the virus, were characterized by very low cytotoxicity (up to 200 nmol/L and 100 nmol/L, respectively) and high efficiency at silencing the target genes and blocking the enteroviral replication in vitro (93% and 60% reduction of the virus infected cells, respectively, at concentrations of 40 nmol/L). The generated pools of overlapping siRNAs targeting the 3C or VP1-VP3 genetic regions showed insignificant cytotoxicity at concentrations up to 200 nmol/L (< 3%) and higher efficacy than the corresponding dsRNAs. We managed to achieve 95% inhibition of the CVB3 Woodruff strain replication in vitro by using siRNAs specific for the 3C coding region of the virus at a concentration of 40 nmol/L, with no cytotoxicity.
No takes yet. Share an insight, caveat, or question.
Petrov et al. (2019) studied Coxsackievirus B3 infection. dsRNAs and siRNA pools targeting viral protease 3C and VP1-VP3 capsid proteins was evaluated on Inhibition of viral replication. siRNAs targeting the 3C coding region of Coxsackievirus B3 achieved 95% inhibition of viral replication in vitro at a concentration of 40 nmol/L with no cytotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: